Position in ABVX
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$25,610
+$13,474 QoQ
Shares Held
230
+155.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 10.869565217391305.ToString("F0")%
Shared 0.ToString("F0")%
None 89.13043478260869.ToString("F0")%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GHP Investment Advisors, Inc. holds $370,214 across 37 Biotechnology names. ABVX ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COYA |
Coya Therapeutics, Inc.
|
26,171 | $103,113 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
1,500 | $84,735 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
168 | $75,018 | |
| 4 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
1,201 | $29,736 | |
| 5 | ABVX |
Abivax S.A.
This page
|
230 | $25,610 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33 | $25,497 | |
| 7 | PBYI |
Puma Biotechnology, Inc.
|
1,170 | $7,476 | |
| 8 | XNCR |
Xencor Inc
|
468 | $5,644 |
All Filings in ABVX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,610 | 230 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $12,136 | 90 | Shares | Sole | 2026-01-27 | |
| No filing history on record for this holder in this stock. | ||||||